注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
ChromaDex Corp是一家全球生物科学公司,从事烟酰胺腺嘌呤二核苷酸(NAD+)的研究,其水平随着年龄的增长而下降。NAD+是一种辅酶,是细胞代谢的调节剂。该公司通过三个分部运营:消费品分部、配料分部以及分析参考标准和服务分部。消费品分部直接向消费者和分销商提供含有这些成分的成品膳食补充剂。配料分部开发和商业化配料技术,并将这些配料作为原材料供应给消费品制造商。分析参考标准和服务分部提供植物化学参考标准和其他研发服务。其成分包括Tru Niagen和Immulina。Tru Niagen是烟酰胺核糖(NR)的一种形式。NR是维生素B3家族的一员。Immulina是一种螺旋藻提取物。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Charles Brenner | - | 2014 | Chief Scientific Advisor & Member of Scientific Advisory Board |
Frank Louis Jaksch | 55 | 1999 | Co-Founder & Chairman |
John Walker | - | 2018 | Member of Scientific Advisory Board |
Wing Tak Yu | 47 | 2017 | Non-Executive Director |
Steven D. Rubin | 63 | 2017 | Lead Independent Director |
J. Bruce German | - | 2014 | Member of Scientific Advisory Board |
Robert N. Fried | 63 | 2015 | CEO & Director |
Roger D. Kornberg | 76 | 2014 | Chairman of the Scientific Advisory Board |
Brunie H. Felding | - | 2019 | Member of the Scientific Advisory Board |
Rudolph Emile Tanzi | 64 | 2017 | Member of Scientific Advisory Board |
David L. Katz | 59 | 2021 | Member of Scientific Advisory Board |
Kristin Patrick | 52 | 2022 | Independent Director |
Wang Yu Ng | 51 | 2021 | Non-Executive Director |
Ann Cohen | 62 | 2022 | Independent Director |
Vilhelm Bohr | - | 2023 | Member of Scientific Advisory Board |
Hamed Shahbazi | 48 | 2022 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核